260 related articles for article (PubMed ID: 11397667)
21. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer JL; Leahy KM; Koki AT; Zweifel BS; Settle SL; Woerner BM; Edwards DA; Flickinger AG; Moore RJ; Seibert K
Cancer Res; 2000 Mar; 60(5):1306-11. PubMed ID: 10728691
[TBL] [Abstract][Full Text] [Related]
22. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2: a potential target in breast cancer.
Wang D; Dubois RN
Semin Oncol; 2004 Feb; 31(1 Suppl 3):64-73. PubMed ID: 15052544
[TBL] [Abstract][Full Text] [Related]
24. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
25. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibition and prevention of cancer.
Giercksky KE
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):821-33. PubMed ID: 11566043
[TBL] [Abstract][Full Text] [Related]
27. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
28. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
29. The new NSAIDs: cox-2 inhibitors.
Capriotti T
Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
[No Abstract] [Full Text] [Related]
30. Cyclooxygenase-2 and its role in colorectal cancer development.
Wendum D; Masliah J; Trugnan G; Fléjou JF
Virchows Arch; 2004 Oct; 445(4):327-33. PubMed ID: 15340847
[TBL] [Abstract][Full Text] [Related]
31. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
32. Approach to angiogenesis inhibition based on cyclooxygenase-2.
Masferrer J
Cancer J; 2001; 7 Suppl 3():S144-50. PubMed ID: 11779086
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
34. COX-2-specific inhibition: implications for clinical practice.
Pascucci RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
Bresalier RS
Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
[No Abstract] [Full Text] [Related]
36. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].
Burdan F; Korobowicz A
Pol Merkur Lekarski; 2003 Apr; 14(82):348-51. PubMed ID: 12868200
[TBL] [Abstract][Full Text] [Related]
37. Role of cyclooxygenase-1 and -2 in health and disease.
Lipsky PE
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):8-12. PubMed ID: 10193997
[TBL] [Abstract][Full Text] [Related]
38. Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.
Subongkot S; Frame D; Leslie W; Drajer D
Pharmacotherapy; 2003 Jan; 23(1):9-28. PubMed ID: 12523457
[TBL] [Abstract][Full Text] [Related]
39. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth.
Mann M; Sheng H; Shao J; Williams CS; Pisacane PI; Sliwkowski MX; DuBois RN
Gastroenterology; 2001 Jun; 120(7):1713-9. PubMed ID: 11375952
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.
Udd L; Katajisto P; Rossi DJ; Lepistö A; Lahesmaa AM; Ylikorkala A; Järvinen HJ; Ristimäki AP; Mäkelä TP
Gastroenterology; 2004 Oct; 127(4):1030-7. PubMed ID: 15480979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
